CCN1 and breast cancer: We have shown that expression of CYR61 is up-regulated by geranylgeranylation signaling that activates the YAP/TAZ-mediated cell migration in the triple negative (ER-/PR-/Her2-) breast cancer MDA-MB-231 cells [21].